Medicare should cover anti-obesity drugs
January 6, 2025
Washington Times
The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s. Congress is also considering such a move.
Expanding coverage to these patient groups makes sense.
Read More